Metastatic Pancreatic Ductal Andenocarcinoma (mPDAC) is an aggressive type of cancer that is most frequently detected at advanced stages with…
featured news
Molecular analysis of ductal carcinoma in situ (DCIS), the most common precursor of invasive breast cancer, has led to the…
VHIO takes part in this European project to expand tumour genome interpretation for personalised cancer treatment 21 – 23 November…
Published in ESMO Open, results of a phase I first-in-human study co-authored by investigators at the Vall d’Hebron Institute of…
Presented at the 45th annual San Antonio Breast Cancer Symposium® (2022 SABCS®), primary results of the multicenter international POSITIVE study…
Presented today (1) at the 45th annual San Antonio Breast Cancer Symposium® (2022 SABCS®), results of the phase II SERENA-2…
Recently published in Nature Reviews Gastroenterology & Hepatology*, a comprehensive Review focused on gastric cancer and gastro-oesophageal junction cancer (GC-GOJC)…
Recently published in Clinical Cancer Research*, a journal of the American Association for Cancer Research (AACR), VHIO investigators have established…
Results of a study led by María Abad, Principal Investigator of VHIO’s Cellular Plasticity and Cancer Group, identify a new…
Published today, Clarivate has revealed its annual #HighlyCited2022 researchers list. Featuring among the world’s elite scientists at academic research institutes and…
